877Phase 2 study 2000mg of intravesical gemcitabine in marker lesions
F.M. Calais da Silva, F.E. Calais da SilvaVolume:
4
Year:
2005
Language:
english
DOI:
10.1016/s1569-9056(05)80881-4
File:
PDF, 166 KB
english, 2005